Vaxcyte, Inc. Quarterly Operating Income (Loss) in USD from Q1 2019 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Vaxcyte, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2019 to Q3 2024.
- Vaxcyte, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$140M, a 23.8% decline year-over-year.
- Vaxcyte, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$604M, a 68.8% decline year-over-year.
- Vaxcyte, Inc. annual Operating Income (Loss) for 2023 was -$468M, a 102% decline from 2022.
- Vaxcyte, Inc. annual Operating Income (Loss) for 2022 was -$232M, a 124% decline from 2021.
- Vaxcyte, Inc. annual Operating Income (Loss) for 2021 was -$104M, a 15.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)